跳至主要内容
临床试验/NCT05847790
NCT05847790已完成不适用

Remote Pregnancy Monitoring to Improve Access: The REACTIVE Trial

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2023年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
2
主要终点
Overall Fetal Testing Completion Rate

研究概览

简要总结

The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy
  • Gestational age between 30 weeks 0 days and 35 weeks 6 days
  • Pregnant patients who have clinical indication for fetal surveillance with NSTs (based on UPHS Health System clinical guidelines for antenatal monitoring)
  • Able to provide written consent
  • English speaking

排除标准

  • Multiple gestations
  • Maternal pre-gravid BMI greater than 45kg/m2
  • Presence of an implanted pacemaker or defibrillator
  • Active abdominal skin infection
  • A known amniotic fluid index (AFI) less than 5cm or greater than 25cm on the most recent ultrasound (if available) prior to randomization
  • Delivery is planned within 2 weeks of potential randomization

结局指标

主要结局

Overall Fetal Testing Completion Rate

时间窗: from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.

percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed

Fetal Testing Completion Rate in Black versus non-Black subjects

时间窗: from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.

Comparison between Black and non-Black subjects' percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed.

次要结局

  • Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Obstetrics outcomes: Number of participants with an Indication for labor induction(time of labor induction)
  • Fetal Monitoring outcomes: Frequency of provider recommended prolonged monitoring(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Fetal Monitoring outcomes: Number of times a NST is not completed within the prescribed window(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Obstetrics outcomes: Mode of delivery(time of delivery)
  • Obstetrics outcomes: Number of participants with an Admission to the neonatal intensive care unit(from delivery to 6 weeks post-delivery)
  • Cost-effectiveness outcomes: Productivity loss survey(at three timepoints, at time of randomization, 3 weeks after randomization (plus or minus 1 week) and 5 weeks after randomization (plus or minus 1 week))
  • Fetal Monitoring outcomes: Number of visits to the antenatal testing unit(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Fetal Monitoring outcomes: Number of non-reactive NSTs(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Obstetrics outcomes: Gestational age at delivery(time of delivery)
  • Obstetrics outcomes: Number of participants with Preterm delivery(time of delivery)
  • Obstetrics outcomes: Composite neonatal morbidity score(from delivery to 6 weeks post-delivery)
  • Obstetrics outcomes: Neonatal cord blood pH(time of delivery)
  • Obstetrics outcomes: Apgar scores(five and ten minutes after delivery)
  • Obstetrics outcomes: Admission to the neonatal intensive care unit for greater than 48 hours(from delivery to 6 weeks post-delivery)
  • Obstetrics outcomes: Maternal length of stay(from delivery to discharge, up to 6 weeks post-delivery)
  • Fetal Monitoring outcomes: Number of biophysical profiles performed for non-reactive NST tests(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit directly related to a fetal monitoring visit(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Obstetrics outcomes: Number of participants with an Indication for cesarean section(time of delivery)
  • Fetal Monitoring outcomes: Time on NST monitor(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Fetal Monitoring outcomes: Frequency of recommendation for delivery based on findings on fetal monitoring result(from 32 weeks gestational age to delivery, average of 10 weeks after enrollment.)
  • Obstetrics outcomes: Neonatal length of stay(from birth to discharge, up to 6 weeks after birth)
  • Cost-effectiveness outcomes: Costs(from 32 weeks to delivery, average of 10 weeks after enrollment.)
  • Implementation outcomes: Theory-informed Acceptability Questionnaire(at time of delivery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samuel Parry, MD

Professor of OBGYN

University of Pennsylvania

研究点 (2)

Loading locations...

相似试验